The following is a summary of “Hydrophobic and Hydrophilic IOLs in Patients with Uveitis – A Randomised Clinical Trial,” published in the February 2025 issue of Clinical Ophthalmology by Pålsson et al.
Researchers conducted a retrospective study to compare the inflammatory response, visual acuity, and complications of 2 intraocular lenses (IOLs) in patients with and without uveitis.
They randomized patients with and without uveitis, eligible for cataract surgery, to receive either a hydrophobic or hydrophilic square-edged IOL. In cases of bilateral surgery, 1 eye received a hydrophobic IOL and the other a hydrophilic IOL. The outcome measures included visual acuity, flare, and central foveal thickness.
The results showed 34 (61%) patients with uveitis (52 eyes) and 22 (39%) patients with non-uveitis (38 eyes) and no significant difference in corrected distance visual acuity (CDVA) was observed between the 2 IOL materials. Flare measurements at 6 months post-surgery showed no significant difference between eyes receiving hydrophilic or hydrophobic IOLs; mean differences were − 3.2 (SD ± 20.7) ph/ms in uveitis eyes (P = 0.53) and − 0.6 (SD ± 7.5) ph/ms in non-uveitis eyes (P = 0.77). No significant difference in cystoid macular edema (CME) was found in patients with uveitic receiving hydrophobic (n = 2; 8.0%) vs hydrophilic IOLs (n = 6; 22.2%; P = 0.25).
Investigators concluded that neither hydrophobic nor hydrophilic IOLs demonstrated superiority regarding postoperative inflammation or CME rates in patients with uveitic undergoing cataract surgery, though both types of IOLs improved CDVA.
Create Post
Twitter/X Preview
Logout